MarketInOut Stock Screener Log In | Sign Up
 

Penumbra Inc

NYSE • Healthcare • Medical Devices • Quote as of 05/29/2026
Penumbra Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization12,560 mln
Float38.23 mln
Earnings Date08/04/2026

EPS

4.32
Stretched

P / E

73.67
Richly valued

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-2.53
Likely reliable

1-Year Forecast

363
Modest upside

Relative Strength

23 / 100
Significantly lagging

Business Description

Penumbra Inc. is a California-based medical device company founded in 2004 that develops and sells a broad range of tools for treating complex vascular and neurovascular conditions. Its products help physicians remove blood clots, restore blood flow, and treat aneurysms in both the brain and the body, with offerings sold across the United States and in international markets. The company reaches its customers through a combination of its own sales teams and third-party distributors.

Key Fundamentals

EPS4.32
P/E73.67
ROE13.79
RPS35.73
ROIC15.00
ROA10.61
Interest Cover144
EBITDA, mln224
EV / EBITDA55.68
EV / EBIT60.39
Revenue, mln1,404
EV / Revenue8.88

Financial Strength

Altman Z-Score21.25
Piotroski F-Score 9 / 9
Beneish M-Score-2.53
Price to Intrinsic Value7.24
Price to Graham Number5.93
1-Year Target Price363
Shiller PE Ratio336
Short Ratio3.92
Short % of Float5.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.92% 13 / 100   
1 Month -2.01% 22 / 100   
2 Months -6.21% 21 / 100   
6 Months 6.56% 47 / 100   
1 Year 20.44% 55 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us